Aspen’s investigational cell therapy program for Parkinson’s disease. Under the terms of the agreement, Aspen will integrate Mytos’ iDEM automated cell technology into its 22,000-square ...
SAN DIEGO, Jan. 8, 2025 /PRNewswire/ -- Aspen Neuroscience ... ANPD001, an investigational cell therapy program for treating people with Parkinson's disease (PD), is currently being studied ...